| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Estrogen receptor pathway 0.939035217519976 3.9060075144582256 9.38335949465241e-05 0.0543922595094522 0.0025420373903694 2 Q15067 1 |
| Electron transport chain oxphos system in mitochondria 0.5994745979038159 3.647134111977857 0.000265181532238 0.1462092619654189 0.0054499376970311 53 P56385,P14406,Q9UDW1,P20674,P00846,O75438,O43676,P06576,O75306,P09669,O75964,P00403,P12236,O75880,O95168,O95298,P13073,P14927,P24539,O14949,Q9UII2,P12235,P36542,O75489,P03886,P22695,P15954,P10606,P56134,O14548 30 |
| Nuclear receptors in lipid metabolism and toxicity 0.8224326723882823 3.340293307880341 0.0008368995099359 0.3928630793269453 0.0113361842709503 2 P08183 1 |
| Nonalcoholic fatty liver disease 0.560080076542384 3.237220901507922 0.0012069994051919 0.5131533710185364 0.0141053263822435 52 O43674,Q9UDW1,P14406,P20674,O75438,O43676,O75306,P09669,P00403,P31749,Q9NX14,P21912,P54619,O95168,Q96J02,Q86Y39,O95298,Q9Y6M9,P13073,P14927,P31751,Q07812,O14949,P56556,O75489,P22695,P49841,P05198,P15954,P10606,O14548 31 |
| Proteoglycan biosynthesis 0.8744447734675714 2.9201783590374717 0.0034983110560886 0.8761456369331521 0.0285615532798471 4 Q9NX62,Q8NCH0,Q8TB61 3 |
| Sphingolipid metabolism in senescence 0.8162756632101629 2.9064407987042413 0.0036556606686679 0.8872707011402861 0.0289822010549121 12 P04062,O15269,P24941,Q96G23,Q16739,Q13510 6 |
| Leptininsulin signaling overlap 0.7380881917727171 2.9046009625273252 0.0036772158391105 0.8887149194441442 0.0289822010549121 2 P31749 1 |
| Autosomal recessive osteopetrosis pathways 0.7377922462266976 2.903029611619022 0.0036957169130424 0.8899397698930172 0.0289822010549121 2 P51798 1 |
| Bmp signaling in eyelid development 0.7315773897602875 2.869959973295245 0.0041052376205006 0.9138579495500584 0.0305840202727297 2 P27361 1 |
| Complement and coagulation cascades 0.7862696437465022 2.8173158932006466 0.0048426869679276 0.9446042642038542 0.0331751888837343 3 P10909 1 |
| Overview of nanoparticle effects 0.7842287603118944 2.8071882430061197 0.0049976027970024 0.949512980533711 0.0338255934491151 3 P09601 1 |
| Sphingolipid metabolism overview 0.8530836729080515 2.7111141946021897 0.0067057527409826 0.9818682193589786 0.0434416155828874 9 O95470,P27544,Q96G23,Q16739,Q13510 5 |
| Sphingolipid metabolism integrated pathway 0.8530836729080515 2.7111141946021897 0.0067057527409826 0.9818682193589786 0.0434416155828874 9 O95470,P27544,Q96G23,Q16739,Q13510 5 |
| Cellular proteostasis 0.8259491564363725 2.6965295523715587 0.007006618014308 0.9848634458686611 0.0449026272744901 4 O15212 1 |
| Sphingolipid pathway 0.8162828576588491 2.6742552413687735 0.0074895424548067 0.9886730113463752 0.0469298176565846 10 O95470,P04062,Q96G23,Q16739,Q13510 5 |
| Vitamin d metabolism 0.8205297165933134 2.671150915266406 0.007559165260121 0.989136826717852 0.0469298176565846 4 P04062 1 |
| Mitochondrial complex iv assembly 0.7533508653750761 2.660903564798192 0.0077931273769333 0.990560921149549 0.04758195931626 13 P13073,Q8N8Q8,P14406,P20674,P15954,Q9Y2R0,P09669,P00403 8 |
| Oxidation by cytochrome p450 0.8653604286306336 2.6362567263080954 0.0083826283702603 0.9933763206571112 0.049465807016586 5 Q16850,Q6UW02,O43169 3 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.7409709887507272 2.5895058677091307 0.0096113784810984 0.9968365373345612 0.0555896625145776 3 P31749,P31751 2 |
| Mitochondrial complex iii assembly 0.7674242718980602 2.5755676902348976 0.0100075682722335 0.9975077177919968 0.0568048637166783 11 Q9UDW1,P22695,O14949 3 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.791516375472979 2.5339387022454383 0.0112788459679329 0.9988412216367772 0.0600195731865002 4 P09601 1 |
| Triacylglyceride synthesis 0.7226169330964958 2.4953725734456382 0.0125824938798697 0.9994721745871008 0.0646479857965722 3 O00116,Q9HCL2 2 |
| Serotonin and anxiety 0.6593666765315229 2.475490005391212 0.0133053485739882 0.999658859468706 0.0666385525218234 2 Q06787 1 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8428028197551916 2.41715382821893 0.0156424049360104 0.999916990777697 0.0751844624343727 7 Q15125,Q16850,Q15392,O75845 4 |
| Metabolism of spingolipids in er and golgi apparatus 0.8094051631798964 2.383160278694066 0.0171647191572634 0.999966999552926 0.07955928791632 5 O95470,Q10472,Q16739 3 |
| Inclusion body myositis 0.7007794368232529 2.3819754114315033 0.0172200472167873 0.9999680884267944 0.07955928791632 3 P05067 1 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.6980461811722912 2.367674650484434 0.017900269238815 0.9999788781078104 0.0813221642217458 3 P00533,P27361 2 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7567923901873855 2.366698637814891 0.0179475402905167 0.9999794754382328 0.0813221642217458 4 Q03252,O60725 2 |
| Glycerolipids and glycerophospholipids 0.8165157275879993 2.2982191703090433 0.0215493181526571 0.9999977027494052 0.0958462210371915 7 Q9UG56,Q9BVG9,Q86UL3,Q9HBU6,Q9HCL2 5 |
| Ferroptosis 0.5605742685234354 2.2463562557849337 0.0246811978944914 0.9999996600840334 0.1061155322498712 23 P48637,P45880,P16435,P09601,Q9Y277,Q96QD8,Q9UKU0 7 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.7796208530805664 2.2453071537459732 0.0247484211119666 0.9999996737649612 0.1061155322498712 5 Q07820,P31749,Q07812,Q9BXK5 4 |
| Kennedy pathway from sphingolipids 0.820148148148127 2.2100699979041636 0.0271003046825799 0.9999999226307902 0.1121651499362337 6 Q9UG56,O95470,Q9BVG9,P48651,Q9HBU6 5 |
| Oxidative phosphorylation 0.5052290711916322 2.1775704224522765 0.029438033579602 0.9999999815554506 0.1193542041730804 32 P56385,O95298,Q9Y6M9,P56556,O75489,O75964,O43674,P03886,P24539,O95168,P00846,P51970,O75438,P56134,P06576,O75306,Q86Y39,O75947 18 |
| Glycosaminoglycan degradation 0.7892708950800245 2.1732246602875738 0.0297634126220047 0.9999999848964845 0.1198580670453705 7 P07686,P15586,P06865,P08236,P16278,P54802 6 |
| Heme biosynthesis 0.7622908903001904 2.1640912456711434 0.0304573472521487 0.9999999901398372 0.121829389008595 5 P22830 1 |
| Nanomaterial induced apoptosis 0.7533465549873853 2.1218856588077624 0.0338473410366071 0.9999999987774432 0.131849772926914 5 O43464,O95831 2 |
| Il17 signaling pathway 0.6982528871779629 2.077227964955781 0.0377805239765858 0.9999999998925048 0.1425138752534503 4 P31749,P49841,P27361 3 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.6956463305462106 2.064120181478589 0.0390063229283179 0.9999999999497152 0.1462123802847642 4 Q07820,P31749 2 |
| Deregulation of rab and rab effector genes in bladder cancer 0.583012725658485 2.0372342407246276 0.0416265740738872 0.9999999999901208 0.154095889118241 2 Q9BXI6 1 |
| Spinal cord injury 0.5367273541149089 2.019306051642876 0.0434554192915686 0.9999999999968354 0.1560206620347884 21 O75116,P62942,P27361,P24941,P08670,Q08722,Q9NQC3,P06493,P14174 9 |
| Reninangiotensinaldosterone system raas 0.6839934613783826 2.005296143186768 0.0449313969036506 0.9999999999987392 0.1603539673926694 4 P16220,P0DP25 2 |
| Degradation pathway of sphingolipids including diseases 0.7451520067633958 1.9671164097124376 0.0491697918568685 0.999999999999911 0.1734035263117967 7 P17900,O43681,P06865,P16278,P06280 5 |
| Amyotrophic lateral sclerosis als 0.6504496618824428 1.947892631686058 0.0514278116422608 0.9999999999999784 0.1783773884719227 11 P07196,P07197,P20339,Q9BUN8,Q07812 5 |
| Mirna regulation of p53 pathway in prostate cancer 0.672311399406473 1.945960350688701 0.0516595025405595 0.9999999999999812 0.1783773884719227 4 O14681 1 |
| 7oxoc and 7betahc pathways 0.6711640948023861 1.9320411068175136 0.0533544323782226 0.9999999999999936 0.1817099525566898 10 O15118,P61916,Q15125 3 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.615473012390281 1.8829033941667337 0.0597134611769798 1.0 0.1966255406711601 13 P31749,Q05086,Q15382,P49841,P31751,P54619,P27361 7 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.5831355033878516 1.836773339808768 0.0662433632035184 1.0 0.2088944151814655 15 O60725,P49841,P42167,O75844,P50402,P55209 6 |
| Ccl18 signaling pathway 0.6744849680299394 1.831516514376348 0.0670234850775266 1.0 0.2091413461057899 9 P07196,P00403,P08670 3 |
| Copper homeostasis 0.673200429348741 1.8248802925385557 0.0680190957841904 1.0 0.2108404341252346 9 P31749,O75880,P49841,P05067,P78536 5 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.4990377801711024 1.8120693139935256 0.0699754871167253 1.0 0.2138737965208629 24 Q9BWD1,Q15125,O75845,Q16850,Q15800,Q15392,Q14534 7 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.686435357794445 1.7843991437783933 0.0743588301124917 1.0 0.2238275896315409 8 P51148,P61020,P20339,O14964,P31943,P27361 6 |
| Omega3 omega6 fatty acid synthesis 0.7069459526906798 1.6935717530165604 0.090346689409809 1.0 0.2606434647858491 6 O15254 1 |
| Familial partial lipodystrophy fpld 0.6877982592491905 1.6926321963657245 0.0905254986756221 1.0 0.2606434647858491 7 O75844,Q03252,O60725,P31751 4 |
| Relationship between inflammation cox2 and egfr 0.6986666666666582 1.654784016740365 0.0979683172697285 1.0 0.2767256734253943 6 P31749,P00533,P31751,Q9H7Z7,P27361 5 |
| Caloric restriction and aging 0.6547359275048712 1.6441002629695454 0.1001554936606323 1.0 0.2802472968156661 5 P43490 1 |
| S1p receptor signal transduction 0.6541822778867392 1.6223414186033922 0.1047302648951662 1.0 0.2903220366396236 8 P31749,Q13510,P31751,Q9H0H5 4 |
| Apoptosis modulation and signaling 0.5783452782757335 1.598368357644986 0.1099610223930407 1.0 0.2992546545490971 12 Q9NR28,Q07820,Q07812,O95831,O43464 5 |
| Statin inhibition of cholesterol production 0.6820287610965461 1.5764737663787518 0.1149166599193294 1.0 0.3056314205154584 6 Q8WTV0 1 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.599799341679904 1.570036594112885 0.1164065980822299 1.0 0.3056314205154584 4 P27361,P62942 2 |
| Tgfbeta receptor signaling 0.599799341679904 1.570036594112885 0.1164065980822299 1.0 0.3056314205154584 4 P27361,P62942 2 |
| Metapathway biotransformation phase i and ii 0.4722871587821444 1.5585298969180206 0.1191076865407694 1.0 0.3099920575471553 22 P48637,Q6UW02,Q99735,Q8NCH0,Q16850,Q7LGA3,P07099 7 |
| Tgfbeta signaling in thyroid cells for epithelialmesenchymal transition 0.6369357747142357 1.555640989923584 0.1197934859033766 1.0 0.3104213808626631 5 P08670,P31749 2 |
| Neovascularisation processes 0.5917009731353527 1.5273259185008208 0.1266799875945135 1.0 0.3240397965936911 4 P31749,P27361 2 |
| Striated muscle contraction pathway 0.6510632037193648 1.5133500725303668 0.1301907599645715 1.0 0.3287868344867993 7 P09493,P08670 2 |
| Sars coronavirus and innate immunity 0.4933412252145682 1.4960747792083795 0.1346341694032931 1.0 0.3334148191290487 2 Q7Z434 1 |
| Mitochondrial complex i assembly model oxphos system 0.4309458850219688 1.4893927961385978 0.1363839644451723 1.0 0.3358877802038127 31 O43674,Q96CU9,O96000,O75438,O43676,O75306,Q8N183,Q9NX14,Q7L592,O95168,O95298,Q9Y6M9,Q9NPL8,Q9BUB7,P56556,Q8TB37,O75489,P03886,P51970 19 |
| Gdnfret signaling axis 0.5331557134399179 1.462470253500047 0.1436123900391857 1.0 0.3507909199317814 3 O94813,P35222 2 |
| Allograft rejection 0.6024262309277955 1.453330188433943 0.1461320993501365 1.0 0.3540436228157778 9 P08670,P08183,P10321,P01889 4 |
| Phosphodiesterases in neuronal function 0.5272978689145984 1.428994558517521 0.1530057974312326 1.0 0.3647658210760586 3 P16220 1 |
| Endothelin pathways 0.6207075358709228 1.3635619749366448 0.1727054665948346 1.0 0.3958940695789287 7 P00403 1 |
| Sarscov2 b117 variant antagonises innate immune activation 0.4708493637170842 1.3568305139793375 0.1748350695197689 1.0 0.3970042340162801 2 Q7Z434 1 |
| Adipogenesis 0.5166781194003824 1.347396497866957 0.1778525679234006 1.0 0.3970042340162801 14 P14174,O75844 2 |
| 16p112 distal deletion syndrome 0.6085005489983806 1.3030112101272588 0.1925709344381339 1.0 0.4204112707880139 7 Q9H2V7 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.5175403554009508 1.2920693425168046 0.1963331317175634 1.0 0.4255074418315192 13 P13674,O75718,Q32P28 3 |
| Nocgmppkg mediated neuroprotection 0.5870712990910274 1.279029600332446 0.2008866324756193 1.0 0.4329751981908959 8 P07196,P30536 2 |
| Glutathione metabolism 0.5817039324347786 1.2780501006130556 0.2012317615752989 1.0 0.4329751981908959 5 O75874 1 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.6183836959690718 1.2732737672723493 0.2029209120543025 1.0 0.4350390776415982 6 P25054,O14641,P49841 3 |
| Vitamin d receptor pathway 0.5214139181032645 1.2599111325510843 0.2077014222877224 1.0 0.4430665664644765 12 P09493,Q96KA5,P24941 3 |
| Influence of laminopathies on wnt signaling 0.5290907230798396 1.2538397208718304 0.2099002684767934 1.0 0.4436497209019333 11 O60725,O75844 2 |
| Calcium regulation in cardiac cells 0.4180624244691477 1.1891477548733205 0.2343815291951347 1.0 0.4833612159179942 25 P16615,Q9UBI6,P62942,P20020,Q13555,P05026,P13861,P63218,P62258,Q9Y3B8,P54709,P0DP25 12 |
| Robo4 and vegf signaling pathways crosstalk 0.4424385912992081 1.179944441553411 0.2380223126867298 1.0 0.4874958706573573 2 O94813 1 |
| Regucalcin in proximal tubule epithelial kidney cells 0.5981415679703426 1.176075306190164 0.2395647846792772 1.0 0.488974697496059 6 P31749,Q8NE86,Q07812 3 |
| Nephrotic syndrome 0.4573069136004284 1.157310063428978 0.247145703474195 1.0 0.4993180992224416 17 Q14108 1 |
| Camkk2 pathway 0.4946626338066643 1.1510243794524109 0.2497222060009809 1.0 0.5028190364073806 13 P09601,Q13501,P16220,O76024 4 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.5020743479824475 1.1437622384909707 0.252722254106652 1.0 0.5054445082133041 12 P07196,Q9NR77 2 |
| Riboflavin and coq disorders 0.5870194052944175 1.1226297102766989 0.2615947917730652 1.0 0.5133354299363764 6 Q8NI60 1 |
| Progeriaassociated lipodystrophy 0.5333059307114647 1.082671231375809 0.2789543777547236 1.0 0.532259998456109 9 O75844 1 |
| Erk pathway in huntingtons disease 0.5063727493541129 1.0723039328251631 0.2835835408998686 1.0 0.5373413461488943 4 P00533,P16220 2 |
| Vitamin b12 metabolism 0.530834660819798 1.0693786070996876 0.2848991029916956 1.0 0.5373413461488943 9 Q8WTV0 1 |
| Mitochondrial complex ii assembly 0.420538620893764 1.0435478683697446 0.2966946229513201 1.0 0.5491614760216981 2 P21912 1 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.5537762977423388 1.0306666471041794 0.3026971705136816 1.0 0.5548964526668279 7 P31749,Q15382,P49841 3 |
| Endometrial cancer 0.4560367204254142 1.018618182323183 0.3083842688400322 1.0 0.5620704104851963 15 P31749,P25054,P35222,P00533,P49841,P31751,Q07812,P27361 8 |
| Vitamin a and carotenoid metabolism 0.5635091772741545 1.0097824602652232 0.3125995252568252 1.0 0.5645736880395994 6 Q8WTV0 1 |
| Vasopressinregulated water reabsorption 0.4211303063213488 0.9732388778489612 0.3304345924892065 1.0 0.5861280271534735 18 Q15907,P51148,P61020,P20339,P16220,Q8NCM8,Q9UJW0 7 |
| Tyrobp causal network in microglia 0.5150651550719231 0.9410789316025312 0.3466644113634434 1.0 0.6059002615032618 5 P61916 1 |
| Dopamine metabolism 0.4021899970405529 0.9298597359788676 0.3524437124801283 1.0 0.6106292227853385 2 P21964 1 |
| Mecp2 and associated rett syndrome 0.3897362711662294 0.9245950397401091 0.3551765941807345 1.0 0.6121319274328486 23 P31749,Q05086,P67809,P31943,P35637,P52597 6 |
| Cytosine methylation 0.5113201183604359 0.9222613935989624 0.356392246340937 1.0 0.6121319274328486 5 P48735 1 |
| Aryl hydrocarbon receptor pathway wp2873 0.526139184452895 0.8937262734923771 0.3714683643543162 1.0 0.6289634805544672 7 Q07812,Q16543,O00170 3 |
| 1q211 copy number variation syndrome 0.482203301972597 0.8886818759412789 0.3741740742317079 1.0 0.6317499950201074 10 Q9NPH0 1 |
| Ebola virus infection in host 0.3496534570246623 0.879399307436302 0.3791848075041857 1.0 0.6366032261197033 43 P31749,O15118,P04439,P09496,P07858,P10321,P01889,P46934,P20339,P51151,P05198,P61916,Q9P253,P78536,O75569 15 |
| Ciliary landscape 0.2863684277600084 0.8299913093570331 0.4065436972674827 1.0 0.6693371369376235 108 P10619,P07196,O15173,Q15024,Q92905,P27105,P09669,P16278,Q13445,P61019,Q13868,O95721,O43805,Q99627,P08670,Q9BT78,Q14566,O43464,P33991,Q15555,P07197,Q96PK6,P06280 23 |
| Nad metabolism 0.4602547954081213 0.8274878757922195 0.4079605912291573 1.0 0.6695505394417628 4 P43490 1 |
| Glycerophospholipid biosynthetic pathway 0.4987325165995441 0.8238170204041447 0.4100435350608111 1.0 0.6695505394417628 8 Q86UL3,O95674,P48651,Q9HCL2 4 |
| Wntbetacatenin signaling pathway in leukemia 0.5206452476470133 0.8058839581380695 0.4203097617753943 1.0 0.6788743035721817 6 P31749,P25054,P49841 3 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.4162059666491006 0.7927066217177212 0.427948771445314 1.0 0.6871931897009727 3 Q15758 1 |
| Alzheimers disease and mirna effects 0.2993908198975283 0.7910424177187904 0.4289192392093319 1.0 0.6871931897009727 88 P28074,P20618,P21796,P16615,P33176,P31749,P45880,P12236,O95197,P05067,Q9Y277,P0DP25,P31751,Q9NQC3,P28072,P12235,Q92542,Q9H0B6,Q8NE86,P49841,P05198,O43242,P78536,P49721,Q96IX5,P27361 26 |
| Aryl hydrocarbon receptor pathway wp2586 0.4954010063977758 0.743422987426455 0.4572256312767564 1.0 0.7133677388506461 7 P00533,Q16543,O00170,P24941 4 |
| Bile acids synthesis and enterohepatic circulation 0.4412200177672344 0.7283939102174638 0.4663724900379191 1.0 0.7225548943428877 4 P51114,P27361,P28482 3 |
| Complement system in neuronal development and plasticity 0.4234937504553643 0.7142962736188129 0.4750439959733943 1.0 0.729316889053538 13 O43464,Q9NR28,Q8N3R9 3 |
| Ketogenesis and ketolysis 0.4679354255125124 0.7072511928968193 0.4794103903254862 1.0 0.7307636640255494 5 O43772,P23786,P53985 3 |
| Extracellular vesiclemediated signaling in recipient cells 0.4976918171700999 0.69878038949341 0.4846892858288953 1.0 0.7350504182036175 6 P31749,P25054,P00533 3 |
| Wnt signaling in kidney disease 0.3949082297217375 0.67459602074158 0.499932461841218 1.0 0.7382451041053562 3 O14641,P35222 2 |
| Development of ureteric collection system 0.429671305892795 0.669205628800288 0.5033643161253865 1.0 0.7382451041053562 4 P05556,O94813,P35222 3 |
| Type i interferon induction and signaling during sarscov2 infection 0.3937240970988926 0.6681225179658005 0.5040553890691628 1.0 0.7382451041053562 3 P42224,Q7Z434 2 |
| Alzheimers disease 0.2921649677123759 0.6667356542076465 0.5049410002426833 1.0 0.7382451041053562 87 P28074,P20618,P21796,P16615,P33176,P31749,P45880,P12236,O95197,P05067,Q9Y277,P0DP25,P31751,Q9NQC3,P28072,P12235,Q92542,Q9H0B6,Q8NE86,P49841,P05198,O43242,P78536,P49721,P27361 25 |
| Endochondral ossification with skeletal dysplasias 0.4540697186498457 0.6621842049707484 0.5078531756429463 1.0 0.7382451041053562 9 Q96QD8,P22413 2 |
| Endochondral ossification 0.4540697186498457 0.6621842049707484 0.5078531756429463 1.0 0.7382451041053562 9 Q96QD8,P22413 2 |
| 15q112 copy number variation syndrome 0.4275984601717379 0.6586722314639288 0.5101062682714512 1.0 0.7397161457172383 4 Q96CW5,Q9BSJ2,Q06787 3 |
| Cholesterol biosynthesis pathway 0.4185457469105239 0.646859247622324 0.5177230429321764 1.0 0.7489391591931484 12 Q14534,Q16850,Q15800 3 |
| Cerebral organic acidurias including diseases 0.4512222091181224 0.6266646074330795 0.5308791083464655 1.0 0.7642607453490179 5 Q9H9P8 1 |
| G1 to s cell cycle control 0.345406704506475 0.6201989910823027 0.5351267856748416 1.0 0.7683867033208741 27 Q9Y619,P16220,P24941,P06493,Q14566,P33991 6 |
| Acute viral myocarditis 0.3958737416699812 0.5878035243833458 0.556664178142426 1.0 0.7918182581691787 14 P31749,P49841,P16220,Q07812,Q9NRG0,P27361 6 |
| Follicle stimulating hormone fsh signaling pathway 0.4239456072366594 0.5715414705418932 0.5676326574024817 1.0 0.7999831769714729 10 P31749,P49815,Q15382,P16220,P27361 5 |
| Serotonin receptor 467 and nr3c signaling 0.4100215599348026 0.5706584126682762 0.5682312144238761 1.0 0.7999831769714729 4 P27361,P16220 2 |
| Wnt signaling pathway 0.3875631891462153 0.5378118562204094 0.590706945836112 1.0 0.820655803539214 14 P31749,P25054,O14641,P49815,P35222,P49841,Q9BTU6 7 |
| Il7 signaling pathway 0.4552467104574064 0.5078758079476818 0.6115404415130559 1.0 0.8417508155699337 6 P31749,P49841,P27361 3 |
| Apoptosis 0.3979624294269491 0.5005647620266164 0.6166774673596349 1.0 0.843297865720107 11 Q07820,P31749,Q9NR28 3 |
| Hepatitis b infection 0.3356172142378089 0.4982970934589553 0.6182746561881138 1.0 0.843297865720107 23 P31749,P31751,Q9Y277,Q07812,O00571 5 |
| Ras and bradykinin pathways in covid19 0.3950251702694609 0.4977614977445662 0.6186521566004612 1.0 0.843297865720107 4 Q99829,Q13464,P28482 3 |
| Cell migration and invasion through p75ntr 0.4232504132489098 0.4962202356476443 0.6197390355459846 1.0 0.843297865720107 5 P31751 1 |
| Small cell lung cancer 0.383131613838609 0.4772906077913568 0.6331551980914014 1.0 0.8539762083008903 13 P31749,Q07812,P31751,P24941 4 |
| P53 transcriptional gene network 0.4205321072340036 0.4418916529030652 0.6585676111484502 1.0 0.8767746342443999 8 Q07812,P04066 2 |
| Regulatory circuits of the stat3 signaling pathway 0.3859217814109571 0.4365096275482698 0.6624670155947014 1.0 0.8786618062228799 11 P16949,Q13263,P00533,Q8WTS6,P27361 5 |
| Melanoma 0.357340505086084 0.4319633607316618 0.6657680428134709 1.0 0.8786618062228799 16 P31749,P16220,P31751,Q07812,P27361,P0DP25 6 |
| Cardiac progenitor differentiation 0.3484310242747124 0.4314005365151037 0.6661771598783377 1.0 0.8786618062228799 3 P13591,P49841 2 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3501551001647103 0.4285169179841117 0.6682748190675856 1.0 0.8792313292809735 17 P33176,O94901,Q9BTV4,Q14739,P42167,Q8WXH0,P50402,P27361,P28482 9 |
| Mitochondrial immune response to sarscov2 0.4064651842940406 0.4252718611064531 0.670638503865463 1.0 0.8803976834885814 9 Q9Y6M9,Q99623,Q86UT6,Q9BQ95 4 |
| Eicosanoid synthesis 0.3148860609647907 0.4205813262642543 0.6740608319898196 1.0 0.8810093330393256 2 Q9H7Z7 1 |
| Pi3kaktmtor vitd3 signaling 0.4321517697130987 0.4098145674249538 0.6819419792511565 1.0 0.8860443832397051 6 P31749,P49841 2 |
| Myometrial relaxation and contraction pathways 0.3234246529708379 0.3979213650774229 0.6906881506790792 1.0 0.8884674720928125 21 P16615,Q9Y3B8,P63218,P16220,P0DP25 5 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.3897185704229231 0.3971011481277824 0.6912928733163921 1.0 0.8884674720928125 10 P31749,P35222,P49841,P31751,P27361 5 |
| Kisspeptinkisspeptin receptor system in the ovary 0.4261273783451875 0.3851170441516477 0.7001507007071828 1.0 0.8911782139811947 6 P31749,P31751 2 |
| T cell receptor and costimulatory signaling 0.397679523161779 0.3835938477610511 0.7012795005992958 1.0 0.8911782139811947 5 P31749 1 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.3698264826494583 0.3764799615861497 0.7065601099165209 1.0 0.8919353711749021 12 P31751,P24941 2 |
| Disruption of postsynaptic signaling by cnv 0.3953060111657663 0.3730934321736083 0.7090789067170842 1.0 0.8919353711749021 9 Q13555,Q06787,P28482,P27361,Q14168 5 |
| Map3k1 role in promoting and blocking gonadal determination 0.3951421800947747 0.3728451101797101 0.7092637266236719 1.0 0.8919353711749021 5 Q13464,P49841,P35222,P28482 4 |
| Tnfalpha signaling pathway 0.3194199182556879 0.36937810615105 0.7118459147006038 1.0 0.8919353711749021 21 Q9Y297,P31749,Q9NR28,Q16543 4 |
| Mfap5mediated ovarian cancer cell motility and invasiveness 0.3653048113561178 0.3611757595843041 0.7179680618676774 1.0 0.8970837838011231 4 P27361,P16220 2 |
| Preimplantation embryo 0.4071581528523795 0.3425788510821033 0.7319153147069233 1.0 0.9015915682375564 7 Q99729,P05023 2 |
| Genes related to primary cilium development based on crispr 0.3481215436910961 0.3417025341327935 0.7325747648242005 1.0 0.9015915682375564 15 Q8WXW3,Q7Z4L5,Q10713,O95684 4 |
| Embryonic stem cell pluripotency pathways 0.3584781100338626 0.3415880249195467 0.7326609504304753 1.0 0.9015915682375564 13 P31749,P25054,O14641,P35222,P00533,P49841,P31751 7 |
| Circadian rhythm genes 0.2912438664050868 0.3376225363835637 0.7356476568668633 1.0 0.9015915682375564 47 O75116,P00813,P50416,Q05086,Q9BWF3,P49841,Q8WXF1,Q14103,P16220,Q9Y297,P23246,P43490,Q15233,P54802 14 |
| Proteasome degradation 0.2935392980340402 0.310928673946397 0.7558548454843086 1.0 0.9091415933208296 42 P28074,P04439,O00231,P10321,P01889,P46934,Q9UL46,O43242,P04843,P61289,P28072 11 |
| Nad biosynthetic pathways 0.3776365754619142 0.3011420072488973 0.7633062097141288 1.0 0.9091415933208296 5 P43490 1 |
| Cardiac hypertrophic response 0.3471718731698955 0.2826884650561311 0.7774156592944637 1.0 0.9138850748313616 13 P31749,P49841,P50750,P31751 4 |
| Primary focal segmental glomerulosclerosis fsgs 0.3064862370790444 0.279581629038772 0.7797985031465262 1.0 0.9148817084160032 21 P08670,Q14108 2 |
| Ppar signaling pathway 0.304368744880087 0.2652694105414441 0.7908019274725737 1.0 0.9169609898320116 21 O15254,Q9UKU0 2 |
| Liver x receptor pathway 0.279076649896428 0.2464585591607561 0.805327280162496 1.0 0.9241881013961244 2 O00767 1 |
| Proximal tubule transport 0.3656597408403184 0.2432592916021525 0.8078045378952379 1.0 0.9241881013961244 9 P08183,P05023 2 |
| Prion disease pathway 0.359134045077094 0.2166903738080902 0.8284496503663721 1.0 0.938699603837182 9 O60216,P30101,P16220,P49711,P14625,Q9UQE7,P27361,P28482 8 |
| Apoptosisrelated network due to altered notch3 in ovarian cancer 0.3220573274173058 0.2004034077338523 0.8411650945634617 1.0 0.9471134534505152 15 P08670,P31749,P05067 3 |
| Head and neck squamous cell carcinoma 0.2984684202077787 0.1874125011815195 0.8513372217317317 1.0 0.9548056229304172 19 P31749,P49815,P62942,Q15382,P00533,P31751 6 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.3583741424383826 0.1836792782268818 0.8542650658943169 1.0 0.9548056229304172 8 P31749,P27361 2 |
| Retinoblastoma gene in cancer 0.2694814319923906 0.1266740421298775 0.8991983916827195 1.0 0.9929077317384296 47 P16949,Q16204,Q9Y619,P24941,P33991,Q14527 6 |
| Notch signaling pathway 0.3125373756743542 0.1196421053312397 0.9047666640332744 1.0 0.9949094681989514 13 P31749,Q92542,P49841,P78536,Q96J02,Q13642 6 |
| Cannabinoid receptor signaling 0.3487407407407438 0.1132204261826074 0.9098558020391888 1.0 0.9968273125282298 6 P17612,Q8NCG7,P10644,P27361,P28482 5 |
| Physiological and pathological hypertrophy of the heart 0.3487407407407433 0.1132204261826063 0.9098558020391896 1.0 0.9968273125282298 6 Q08209,Q9P2K5,P28482,P63000,P61586 5 |
| Resistin as a regulator of inflammation 0.3427882838009345 0.1106977031313458 0.9118560674225672 1.0 0.9971857177685324 7 P31749,P31751 2 |
| Serotonin receptor 2 and elksrfgata4 signaling 0.2616250586740118 0.0838251445036975 0.9331954559510448 1.0 1.0 3 P27361 1 |
| Mirnas involved in dna damage response 0.2890139176784061 0.083773628134927 0.933236415995909 1.0 1.0 4 P04637,P16220,P16104 3 |
| Joubert syndrome 0.2774962003934714 0.0695314154998957 0.9445666272043314 1.0 1.0 19 P41208,Q10713,Q15382,Q8WXW3 4 |
| Onecarbon metabolism and related pathways 0.2997108503417926 0.0672964501182825 0.9463457028795326 1.0 1.0 13 Q9HBU6 1 |
| Il9 signaling pathway 0.3288270764558459 0.0604068723856718 0.951831585282755 1.0 1.0 6 P27361,P50750 2 |
| Hedgehog signaling pathway wp4249 0.3235555555555586 0.0477877753744651 0.9618853792641118 1.0 1.0 6 P17612,P98164,P48729,Q9Y496,Q2M1P5 5 |
| Mammary gland development pathway pregnancy and lactation stage 3 of 4 0.3206799729939615 0.0411489291390246 0.9671771677989498 1.0 1.0 6 P06753,P18031 2 |
| Oxidative damage response 0.2917654028435968 0.031525150444532 0.9748507349560702 1.0 1.0 5 O95429,O95551,P60953,P12004 4 |
| Methionine de novo and salvage pathway 0.3059136847477582 0.0144922561668183 0.9884372572998268 1.0 1.0 7 Q9BV57 1 |
|
|
